JP Morgan Chase
CCEL icon

JP Morgan Chase’s Cryo-Cell International CCEL Stock Holding History

JP Morgan Chase’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11
Closed -$51 – 7466
2025
Q3 		$51 Hold
11
– – ﹤0.01% 7221
2025
Q2 		$57 Sell
11
-84
-88% -$443 ﹤0.01% 6885
2025
Q1 		$605 Buy
95
+84
+764% +$610 ﹤0.01% 6682
2024
Q4 		$82 Hold
11
– – ﹤0.01% 7042
2024
Q3 		$70 Hold
11
– – ﹤0.01% 7054
2024
Q2 		$84 Hold
11
– – ﹤0.01% 6917
2024
Q1 		$82 Buy
11
+2
+22% +$11 ﹤0.01% 6944
2023
Q4 		$52 Sell
9
-98
-92% -$507 ﹤0.01% 7199
2023
Q3 		$563 Buy
+107
New +$626 ﹤0.01% 6708

Other funds holding CCEL

HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase's CCEL Position: Q4 2025 in Review

JP Morgan Chase sold out of Cryo-Cell International (CCEL) in Q4 2025, closing a stake of 11 shares — an estimated $51 sold.

JP Morgan Chase first reported a position in CCEL in Q3 2023 and held it in 9 quarters. The position peaked at $605 in Q1 2025. 17 funds tracked by Wall St. Rank hold CCEL as of Q4 2025.

  • JP Morgan Chase reported no remaining Cryo-Cell International position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 11 Cryo-Cell International shares in Q4 2025, an estimated $51.
  • JP Morgan Chase first reported a position in Cryo-Cell International in Q3 2023 and held it in 9 quarters.
  • JP Morgan Chase's Cryo-Cell International position peaked at $605 in Q1 2025.
  • 17 funds tracked by Wall St. Rank held Cryo-Cell International as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.